Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice

Following curative immunotherapy of B16F10 tumors, ~60% of mice develop a strong antibody response against cell-surface tumor antigens. Their antisera confer prophylactic protection against intravenous challenge with B16F10 cells, and also cross-react with syngeneic and allogeneic tumor cell lines M...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Byong H., Momin, Noor, Moynihan, Kelly D., Silva, Murillo, Li, Yingzhong, Irvine, Darrell J., Wittrup, K. Dane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049297/
https://www.ncbi.nlm.nih.gov/pubmed/33857179
http://dx.doi.org/10.1371/journal.pone.0248903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049297/
https://www.ncbi.nlm.nih.gov/pubmed/33857179
http://dx.doi.org/10.1371/journal.pone.0248903

Ejemplares similares